About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in San Antonio | 152 Studies

Clinical Trials Prostate CancerSan Antonio

Prostate Cancer Clinical Trials in San Antonio

Find 152 clinical trials for prostate cancer near San Antonio, Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in San Antonio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 152 trials

CompletedUrology San Antonio MRI/MicroUS ComparisonThis study compares micro-ultrasound image targeted prostate biopsy with multi-parametric MRI targeted biopsy in men indicated for prostate biopsy due to suspicion of prostate…NCT03762616·San Antonio, Texas TerminatedStudy to Assess the Activity of Nexrutine® in Prostate Cancer PatientsThe purpose of the study is to (1) to determine the rate of PSA decline (the number declining).NCT01705652·San Antonio, Texas CompletedPerformance Evaluation of the AMS CONTINUUM™ Device1. To assess the safety of using the CONTINUUM™ device by monitoring the side effects and complications associated with the Device following a radical prostatectomy.NCT00894933·Little Rock, Arkansas and 5 others CompletedA Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation TherapyParticipants who completed the FE200486 CS21 study (NCT00295750) could enter the FE200486 CS21A study.NCT00451958·Homewood, Alabama and 68 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedSatraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy RegimenPURPOSE: The SPARC trial is designed to compare the combination of the investigational oral cytotoxic drug, satraplatin, and prednisone, versus prednisone alone as second line…NCT00069745·Birmingham, Alabama and 210 others

Active not recruitingMultiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate CancerThis phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate…NCT03697148·Phoenix, Arizona and 43 others

Active not recruitingA Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are DescribedThe purpose of this study is to find out in the real-world setting, if darolutamide is safe and effective for patients diagnosed with prostate cancer that has not spread to other…NCT04122976·Homewood, Alabama and 39 others

CompletedStudy of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate CancerRandomized, double-blind, placebo controlled, dose finding Phase 2 study comparing oral daily dosing of VERU-944 after a week of loading (daily dosing) with placebo to ameliorate…NCT03646162·Glendale, Arizona and 23 others

Active not recruitingA Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate CancerThe main purpose of this study is to determine if the addition of apalutamide to radiotherapy (RT) plus luteinizing hormone-releasing hormone agonist (LHRHa) delays metastatic…NCT04557059·Tucson, Arizona and 140 others

TerminatedDocetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer PatientsThe primary objective of this study is to compare the duration of survival between patients receiving docetaxel in combination with the GVAX® vaccine for prostate cancer versus…NCT00133224·Anchorage, Alaska and 114 others

CompletedPersonal Patient Profile Prostate (P4) Randomized, Multisite TrialThe purpose of this study is to determine whether or not participation in an experimental program called the "P4 program" is useful to men who are faced with choices about…NCT00692653·Augusta, Georgia and 5 others

RecruitingPhase I Study of SYS6043 in Patients With Advanced/Metastatic Solid TumorsThe goal of this clinical trial is to learn if investigational drug called SYS6043 works in adults with advanced or metastatic solid tumors that have spread or cannot be treated…NCT07424547·Plantation, Florida and 4 others

TerminatedA Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate CancerThis is a global, multi-center, open-label, randomized phase 1b/2, active-controlled safety and efficacy study of oral administration of tazemetostat in combination with…NCT04179864·San Diego, California and 23 others

CompletedSafety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate CancerThe study will evaluate if Leuprolide Mesylate is safe and effective in the treatment of subjects with prostate cancer, when administered as two injections twelve weeks apart.NCT03261999·Homewood, Alabama and 20 others

CompletedA Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYXThis is a multi-center, prospective, observational study of patients being treated with ORGOVYX.NCT05467176·Homewood, Alabama and 95 others

RecruitingStandard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerThis phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants…NCT03678025·Gilbert, Arizona and 337 others

TerminatedHC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)This study is a multinational Phase 3, randomized, double-blind, non-inferiority, efficacy and safety study of oral HC-1119 (80 mg/day) versus enzalutamide (160 mg/day) in…NCT03850795·Denver, Colorado and 57 others

Active not recruitingTesting the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE StudyThis phase III trial compares the effect of adding darolutamide to ADT versus ADT alone after surgery for the treatment of high-risk prostate cancer.NCT04484818·Duarte, California and 114 others

TerminatedA Degarelix Trial in Patients With Prostate CancerA phase III extension trial comparing the efficacy and safety of degarelix 3 month depot with the established therapy Zoladex 3 month implant in patients with prostate cancer.NCT01242748·Aurora, Colorado and 62 others

CompletedThe Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate CancerThe study was a three-arm, active-control, multi-centre, parallel group study.NCT00295750·Homewood, Alabama and 34 others

PreviousPage 5 of 8Next

Other Conditions in San Antonio

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma